[Pregabalin under the prison lens. Reflections on an emerging issue]
Related Experiment Video
Updated: Sep 7, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
D Marcot1, H C Castelan Camargo1
1Filière légale du Centre Neuchâtelois de Psychiatrie, site de Préfargier, 2074 Marin Epagnier, Suisse.
Abstract:
The practice of medicine in prison confronts the prescriber with emerging trends in psychotropic drug misuse. We examine the increasing demand for pregabaliun, as we observe it in patients in detention, and offer a reflection on the health issues. We explain our approach to abstaining from prescribing.
Related Concept Videos
The Stanford Prison Experiment
Drug Control Governance: Regulatory Bodies and Their Impact
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Regulation

